EHI
Eagle Health Investments Portfolio holdings
AUM $405M
1-Year Return
14.19%
This Quarter Return
-8.22%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$385M
AUM Growth
-$22.8M
(-5.6%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
5.8%
Top 10 Holdings %
Top 10 Hldgs %
77.48%
Holding
22
New
4
Increased
4
Reduced
5
Closed
2
Top Buys
| 1 |
Exact Sciences
EXAS
|
+$16.8M |
| 2 |
Akero Therapeutics
AKRO
|
+$9.16M |
| 3 |
Ascendis Pharma
ASND
|
+$8.81M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$7.75M |
| 5 |
DexCom
DXCM
|
+$5.63M |
Top Sells
| 1 |
Inspire Medical Systems
INSP
|
+$8.84M |
| 2 |
Natera
NTRA
|
+$8.48M |
| 3 |
United Therapeutics
UTHR
|
+$7.69M |
| 4 |
Insmed
INSM
|
+$5.37M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$2.86M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$46.3B
| $44.4M | 11.53% |
74,990
| – | – |
|
|
2
Natera
NTRA
$23.6B
| $39.6M | 10.27% |
279,764
-60,000
| -18% | -$8.48M |
|
3
Icon
ICLR
$13.3B
| $36.6M | 9.51% |
209,190
| – | – |
|
|
4
Insmed
INSM
$30.3B
| $33.8M | 8.78% |
443,300
-70,400
| -14% | -$5.37M |
|
5
Illumina
ILMN
$15.5B
| $27.2M | 7.07% |
343,361
| – | – |
|
6
BioMarin Pharmaceuticals
BMRN
$10.2B
| $27M | 7.02% |
382,612
-36,600
| -9% | -$2.59M |
|
|
7
Neurocrine Biosciences
NBIX
$13.9B
| $24.9M | 6.46% |
225,100
+70,100
| +45% | +$7.75M |
|
|
8
DexCom
DXCM
$29.6B
| $24.4M | 6.33% |
356,921
+82,370
| +30% | +$5.63M |
|
9
Ultragenyx Pharmaceutical
RARE
$2.79B
| $22.7M | 5.9% |
627,600
| – | – |
|
|
10
Alnylam Pharmaceuticals
ALNY
$60.4B
| $17.7M | 4.6% |
65,656
-10,600
| -14% | -$2.86M |
|
11
Procept Biorobotics
PRCT
$2.11B
| $17.4M | 4.52% |
299,089
+66,000
| +28% | +$3.85M |
|
|
12
Exact Sciences
EXAS
$10.1B
| $16.8M | 4.37% |
+388,650
| New | +$16.8M |
|
|
13
Inspire Medical Systems
INSP
$2.39B
| $12.9M | 3.36% |
81,121
-55,482
| -41% | -$8.84M |
|
14
Agios Pharmaceuticals
AGIO
$2.11B
| $9.69M | 2.52% |
330,830
| – | – |
|
|
15
Akero Therapeutics
AKRO
$3.43B
| $9.16M | 2.38% |
+226,400
| New | +$9.16M |
|
|
16
Ascendis Pharma
ASND
$11.8B
| $8.81M | 2.29% |
+56,500
| New | +$8.81M |
|
17
Transmedics
TMDX
$3.9B
| $6.77M | 1.76% |
100,661
+82,600
| +457% | +$5.56M |
|
18
Intuitive Surgical
ISRG
$156B
| $2.17M | 0.56% |
4,390
| – | – |
|
19
Vir Biotechnology
VIR
$665M
| $1.56M | 0.4% |
+240,500
| New | +$1.56M |
|
20
Immunocore
IMCR
$1.73B
| $1.37M | 0.36% |
46,300
| – | – |
|
|
21
United Therapeutics
UTHR
$18.2B
| – | – |
-21,802
| Closed | -$7.69M |
|
|
GRAL
22
GRAIL, Inc. Common Stock
GRAL
$1.42B
| – | – |
-53,124
| Closed | -$948K |
|